Key facts
- It has raised $2.5M; the latest was Seed Round in Jun 2026.
- Notable investors include Sanabil Venture Studio, Stryber.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Kilow
- ·The full record, as it builds
Funding rounds
No funding rounds for Kilow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kilow
Operator of a mobile application designed to provide a science-backed approach to weight loss tailored for the local population. The company integrates lifestyle coaching, health tracking, and access to modern medical treatments, such as Glucagon-Like Peptide-1 receptor agonists (GLP-1) medications, within a single application.
- Sector
- Healthcare
- HQ
- Riyadh, Saudi Arabia
- Founded
- 2024
- Employees
- 13
- Website
- kilow.app/
- Ownership
- Privately Held (backing)
Kilow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kilow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kilow in its N-PORT filings yet. We sweep new filings monthly.